Quick Answer
Cabaletta Bio, Inc. reported Stockholders Equity of $112.05 million for fiscal year 2025.
Cabaletta Bio, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $112.05M | -26.4% |
| 2024 | $152.34M | -35.5% |
| 2023 | $236.20M | +126.0% |
| 2022 | $104.52M | -11.4% |
| 2021 | $117.96M | +7.7% |
| 2020 | $109.54M | -20.8% |
| 2019 | $138.32M | +1393.9% |
| 2018 | -$10.69M | -4193.2% |
| 2017 | -$249.0K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $139.47M | -20.0% | -21.9% |
| June 30, 2025 | $178.48M | -10.5% | +46.8% |
| March 31, 2025 | $121.55M | -45.2% | -20.2% |
| December 31, 2024 | $152.34M | -35.5% | -12.6% |
| September 30, 2024 | $174.24M | +8.3% | -12.7% |
| June 30, 2024 | $199.52M | +14.6% | -10.0% |
| March 31, 2024 | $221.72M | +141.9% | -6.1% |
| December 31, 2023 | $236.20M | +126.0% | +46.8% |
- Cabaletta Bio, Inc. showed a decrease of -26.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2017–2025 period, Cabaletta Bio, Inc.’s stockholders equity has grown by 45100.4% (from -$249.0 thousand to $112.05 million).
- The most recent figure is from Cabaletta Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: